Niklas Loman

14.5k citations
52 papers · 5.8k · 3 hit papers · h-index 27

Impact in

  • Oncology top 0.5%
    • PARP inhibition in cancer therapy
    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies

Papers in

    • BRCA gene mutations in cancer 32
    • Genomic variations and chromosomal abnormalities 5
    • DNA Repair Mechanisms 8

Niklas Loman

51 papers receiving 5.7k citations

Niklas Loman's Hit Papers

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression 2017 · 417 citations
4170+5+10Years since publication50010001.5k

Peers

Niklas Loman
Comparison fields: 5 of 109
  • Oncology 3.0k
  • Cancer Research 1.4k
  • Reproductive Medicine 673
  • Genetics 1.9k
  • Molecular Biology 2.1k
Replace Kirsten M. Timms with:
Kirsten M. Timms United States
M. William Audeh United States
Judith Balmañà Spain
Rinat Yerushalmi Israel
Nuala McCabe United Kingdom
Elena López‐Knowles United Kingdom
Patricia N. Tonin Canada
Evgeny N. Imyanitov Russia
David S. Boss Netherlands
Heli Nevanlinna Finland
Niklas Loman relative to Kirsten M. Timms United States Kirsten M. Timms's profile →
Citations per field
00.5×1.5×
Kirsten M. Timms · 1×
Citations per year

Countries citing papers authored by Niklas Loman

Since Specialization
Citations

This map shows the geographic impact of Niklas Loman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niklas Loman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niklas Loman more than expected).

Fields of papers citing papers by Niklas Loman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niklas Loman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niklas Loman. The network helps show where Niklas Loman may publish in the future.

Co-authors

The 25 scholars most cited alongside Niklas Loman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Niklas Loman Line = papers co-authored together Niklas Loman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
Hit paper breakdown →
20101748
2
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
Hit paper breakdown →
20141248
3
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Hit paper breakdown →
2017417
4 2015220
5 2013189
6 2001187
7 2005146
8
Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.
1997142
9 1998139
10 2003136
11 2015111
12
BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease.
1998109
13 2016108
14 199991
15 200371
16 200554
17 201151
18 199949
19 200040
20 201440

About Niklas Loman

Niklas Loman is a scholar working on Genetics, Molecular Biology, Oncology, Cancer Research and Reproductive Medicine, having authored 52 papers that have together received 5.8k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (32 papers), DNA Repair Mechanisms (8 papers), Cancer Genomics and Diagnostics (7 papers), Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (7 papers), Genomic variations and chromosomal abnormalities (5 papers), Male Breast Health Studies (3 papers) and Genetic factors in colorectal cancer (3 papers). The work is most often cited by research in Oncology (3.0k citations), Cancer Research (1.4k citations), Reproductive Medicine (673 citations), Genetics (1.9k citations) and Molecular Biology (2.1k citations). Niklas Loman has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Michael Friedländer, M. William Audeh, Åke Borg, Håkan Olsson, Clare L. Scott, Andrew Tutt, Karen H. Lu, Katherine M. Bell‐McGuinn, Rita K. Schmutzler and Mark Wickens. Their work appears in journals such as Breast Cancer Research and Treatment, European Journal of Cancer, Journal of Clinical Oncology, Gynecologic Oncology and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact